Zdrowie i gospodarka · 05/08/2013
FDA Clears CYTOXAN for Sale, Allows for Abbreviated New Drug Applications
The US Food and Drug Administration (FDA) has determined that CYTOXAN (cyclophosphamide) for Injection has not been withdrawn from sale due to safety or effectiveness concerns, paving the way for abbreviated new drug applications (ANDAs) for these products.
Source: Federal Register — Food and Drug AdministrationOpen original release →